.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Accenture
Covington
Colorcon
Moodys
Cantor Fitzgerald
Federal Trade Commission
Cerilliant
US Department of Justice
Teva

Generated: September 23, 2017

DrugPatentWatch Database Preview

Exemestane - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for exemestane and what is the scope of exemestane freedom to operate?

Exemestane
is the generic ingredient in two branded drugs marketed by Upsher-smith Labs, Mylan Pharms Inc, West-ward Pharms Int, Pharmacia And Upjohn, and Alvogen Malta, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are fifteen drug master file entries for exemestane. Seven suppliers are listed for this compound.

Summary for Generic Name: exemestane

Tradenames:2
Patents:0
Applicants:5
NDAs:5
Drug Master File Entries: see list15
Suppliers / Packagers: see list7
Bulk Api Vendors: see list69
Clinical Trials: see list174
Patent Applications: see list6,769
Therapeutic Class:Antineoplastics
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:exemestane at DailyMed

Pharmacology for Ingredient: exemestane

Drug ClassAromatase Inhibitor
Mechanism of ActionAromatase Inhibitors
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms Inc
EXEMESTANE
exemestane
TABLET;ORAL203315-001Mar 10, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Alvogen Malta
EXEMESTANE
exemestane
TABLET;ORAL200898-001Jul 28, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Upsher-smith Labs
EXEMESTANE
exemestane
TABLET;ORAL209208-001Jul 26, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
AROMASIN
exemestane
TABLET;ORAL020753-001Oct 21, 1999ABRXYesYes► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
EXEMESTANE
exemestane
TABLET;ORAL077431-001Apr 1, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: exemestane

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn
AROMASIN
exemestane
TABLET;ORAL020753-001Oct 21, 1999► Subscribe► Subscribe
Pharmacia And Upjohn
AROMASIN
exemestane
TABLET;ORAL020753-001Oct 21, 1999► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Medtronic
Accenture
Moodys
UBS
Daiichi Sankyo
Mallinckrodt
McKinsey
Baxter
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot